Snowball logo
logo
GDER

GDERF

GDERF โ€ข OTCGREY
$218.66-$21.29ย  (8.87%)
Estimate
P/E
59.9
EPS
3.65
Beta
-0.05
Dividends
Div. yield, TTM
0.2%
Annual payout, TTM
$0.44
Payout
6.69%
Dividend growth streak
1 year
Div.rating
About the company
Ticker
GDERF
ISIN
Country
Switzerland
Sector (GICS)
Other
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.

Frequently asked questions

What sector does GDERF (GDERF) operate in?

GDERF belongs to the Other sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is GDERF (GDERF) current stock price?

As of the latest data, GDERF stock price is $218.66, with a previous close of $239.95. GDERF lost -$21.29 in the last trading session, representing a -8.87% loss.

What is GDERF (GDERF) current market capitalization?

GDERF market cap is approximately 50.99 billion.

What is GDERF (GDERF) Earnings Per Share (EPS)?

The trailing EPS is $3.65.

What is GDERF (GDERF) Price-to-Earnings (P/E) ratio?

GDERF current P/E ratio is 59.91.

Does GDERF (GDERF) pay dividends?

Yes. GDERF pays other dividends with an annualized yield of 0.2% and an estimated annual payout of $0.44 per share.

When is GDERF (GDERF) next earnings report?

GDERF is expected to release its next earnings report on December 31, 2026.

What is GDERF (GDERF) beta (volatility) score?

GDERF has a beta of -0.050, indicating lower volatility than the overall market.